Mounjaro Sales Skyrocket 502% in India’s GLP-1 Showdown

Mounjaro’s sales have skyrocketed by 502%! This isn’t just a spike; it’s a full-blown culinary revolution in the diabetes arena, raking in ₹1,256 crore in just a year! Injectables are dominating, making up 86% of the market. But hold on, because generics are stepping into the ring, and it’s about to get spicy! Get ready for a showdown!